By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eleven Biotherapeutics 

215 First Street
Suite 400
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-871-9911 Fax: 617-858-0911



Company News
Eleven Bio (EBIO) Announces Effectiveness Of Investigational New Drug Application For EBI-031 7/8/2016 10:53:44 AM
2 Fallen Biotech Stocks Worth Chasing 7/7/2016 8:01:17 AM
Cambridge's Eleven Bio (EBIO) Pink Slips 70% of Workforce in Restructuring 6/23/2016 5:57:38 AM
Eleven Bio (EBIO) Announces Investigational New Drug Application Submission To Initiate Clinical Trials Of EBI-031 For Ocular Diseases 6/13/2016 10:24:35 AM
Struggling Eleven Bio (EBIO) Forges Deal Worth $270 Million with Pharma Giant Roche (RHHBY) 6/13/2016 6:32:59 AM
Eleven Biotherapeutics (EBIO) Reports First Quarter 2016 Financial Results 5/5/2016 10:59:51 AM
Eleven Biotherapeutics (EBIO) To Present Data At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/29/2016 10:37:35 AM
Eleven Biotherapeutics (EBIO) Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Strategic Update 3/24/2016 7:59:17 AM
Struggling Eleven Biotherapeutics (EBIO) Gets Delisting Notice from Nasdaq After Back-to-Back Clinical Trial Failures 3/10/2016 6:07:38 AM
Albumedix And Eleven Biotherapeutics (EBIO) Announce Albumin Variant Technology Agreement 1/26/2016 10:18:47 AM